Abstract
The specific mechanism, of uptake of a nanoparticle by a cell and the subcellular localisation are of great importance regarding the potential effect of the nanomaterial inside the cell. In order to study health risks and the potential of a nanoparticle to be used in biomedical applications, cellular internalization has to be investigated in great detail. This chapter highlights most relevant routes of nanoparticle uptake and includes current approaches for the visualization of particle uptake at the nano-level.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beddoes, C.M., Case, C.P., Briscoe, W.H.: Understanding nanoparticle cellular entry: a physicochemical perspective. Adv. Colloid Interface Sci. 48–68 (2015). https://doi.org/10.1016/j.cis.2015.01.007
Abbas, K., Cydzik, I., Del Torchio, R., Farina, M., Forti, E., Gibson, N., et al.: Radiolabelling of TiO2 nanoparticles for radiotracer studies. J Nanopart. Res. 12, 2435–2443 (2010). https://doi.org/10.1007/s11051-009-9806-8
Maynard, A.D., Aitken, R.J., Butz, T., Colvin, V., Donaldson, K., Oberdörster, G., et al.: Safe handling of nanotechnology. Nature 444, 267–269 (2006). https://doi.org/10.1038/444267a
Nel, A., Xia, T., Mädler, L., Li, N.: Toxic potential of materials at the nanolevel. Science 622–627 (2006). https://doi.org/10.1126/science.1114397
Service, R.F.: Priorities needed for nano-risk research and development. Science. 45 (2006). https://doi.org/10.1126/science.314.5796.45
Barnard, A.S.: Nanohazards: Knowledge is our first defence. Nat. Mater. 5, 245–248 (2006). https://doi.org/10.1038/nmat1615
Handy, R.D., Von Der Kammer, F., Lead, J.R., Hassellöv, M., Owen, R., Crane, M.: The ecotoxicology and chemistry of manufactured nanoparticles. Ecotoxicology 287–314 (2008). https://doi.org/10.1007/s10646-008-0199-8
Linse, S., Cabaleiro-Lago, C., Xue, W.-F., Lynch, I., Lindman, S., Thulin, E., et al.: Nucleation of protein fibrillation by nanoparticles. Proc. Natl. Acad. Sci. 104, 8691–8696 (2007). https://doi.org/10.1073/pnas.0701250104
Lunov, O., Zablotskii, V., Syrovets, T., Röcker, C., Tron, K., Nienhaus, G.U., et al.: Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages. Biomaterials 32, 547–555 (2011). https://doi.org/10.1016/j.biomaterials.2010.08.111
Lunov, O., Syrovets, T., Röcker, C., Tron, K., Ulrich Nienhaus, G., Rasche, V., et al.: Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. Biomaterials 31, 9015–9022 (2010). https://doi.org/10.1016/j.biomaterials.2010.08.003
Yameen, B., Choi, W.I., Vilos, C., Swami, A., Shi, J., Farokhzad, O.C.: Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release. 190, 485–499 (2014). https://doi.org/10.1016/j.jconrel.2014.06.038
Treuel, L., Jiang, X., Nienhaus, G.U.: New views on cellular uptake and trafficking of manufactured nanoparticles. J. R. Soc. Interface 10, 20120939–20120939 (2013). https://doi.org/10.1098/rsif.2012.0939
AshaRani, P.V., Mun, G.L.K., Hande, M.P., Valiyaveettil, S.: Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3, 279–290 (2009). https://doi.org/10.1021/nn800596w
Chithrani, B.D., Ghazani, A.A., Chan, W.C.W.: Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6, 662–668 (2006). https://doi.org/10.1021/nl052396o
Rejman, J., Oberle, V., Zuhorn, I.S., Hoekstra, D.: Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J. 377, 159–169 (2004). https://doi.org/10.1042/bj20031253
Labhasetwar, V., Song, C., Humphrey, W., Shebuski, R., Levy, R.J.: Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J. Pharm. Sci. 87, 1229–1234 (1998). https://doi.org/10.1021/js980021f
Arbab, A.S., Bashaw, L.A., Miller, B.R., Jordan, E.K., Lewis, B.K., Kalish, H., et al.: Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 229, 838–846 (2003). https://doi.org/10.1148/radiol.2293021215
Sun, X., Rossin, R., Turner, J.L., Becker, M.L., Joralemon, M.J., Welch, M.J., et al.: An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution. Biomacromolecules 6, 2541–2554 (2005). https://doi.org/10.1021/bm050260e
Nativo, P., Prior, I.A., Brust, M.: Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 2, 1639–1644 (2008). https://doi.org/10.1021/nn800330a
Holzapfel, V., Lorenz, M., Weiss, C.K., Schrezenmeier, H., Landfester, K., Mailänder, V.: Synthesis and biomedical applications of functionalized fluorescent and magnetic dual reporter nanoparticles as obtained in the miniemulsion process. J. Phys. Condens. Matter. 18 (2006). https://doi.org/10.1088/0953-8984/18/38/s04
Rajendran, L., Knölker, H.-J., Simons, K.: Subcellular targeting strategies for drug design and delivery. Nat. Rev. Drug Discov. 9, 29–42 (2010). https://doi.org/10.1038/nrd2897
Huang, J.G., Leshuk, T., Gu, F.X.: Emerging nanomaterials for targeting subcellular organelles. Nano Today 478–492 (2011). https://doi.org/10.1016/j.nantod.2011.08.002
Kettiger, H., Schipanski, A., Wick, P., Huwyler, J.: Engineered nanomaterial uptake and tissue distribution: from cell to organism. Int. J. Nanomed. 3255–3269 (2013). https://doi.org/10.2147/ijn.s49770
Aderem, A., Underhill, D.M.: Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17, 593–623 (1999). https://doi.org/10.1146/annurev.immunol.17.1.593
Hillaireau, H., Couvreur, P.: Nanocarriers’ entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci. 66, 2873–2896 (2009). https://doi.org/10.1007/s00018-009-0053-z
Silverstein, S.C.: Phagocytosis of microbes: insights and prospects. Trends Cell Biol. 5, 141–142 (1995). https://doi.org/10.1016/S0962-8924(00)88967-9
Owens, D.E., Peppas, N.A.: Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 93–102 (2006). https://doi.org/10.1016/j.ijpharm.2005.10.010
Underhill, D.M., Goodridge, H.S.: Information processing during phagocytosis. Nat. Rev. Immunol. 492–502 (2012). https://doi.org/10.1038/nri3244
Rabinovitch, M.: Professional and non-professional phagocytes: an introduction. Trends Cell Biol. 5, 85–87 (1995). https://doi.org/10.1016/S0962-8924(00)88955-2
Dobrovolskaia, M.A., Mcneil, S.E.: Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2, 469–478 (2007)
Conner, S.D., Schmid, S.L.: Regulated portals of entry into the cell. Nature. 422, 37–44 (2003). https://doi.org/10.1038/nature01451
Falcone, S., Cocucci, E., Podini, P., Kirchhausen, T., Clementi, E., Meldolesi, J.: Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events. J. Cell Sci. 119, 4758–4769 (2006). https://doi.org/10.1242/jcs.03238
Mercer, J., Helenius, A.: Virus entry by macropinocytosis. Nat. Cell Biol. 510–520 (2009). https://doi.org/10.1038/ncb0509-510
Kolb-Mäurer, A., Wilhelm, M., Weissinger, F., Bröcker, E.-B., Goebel, W.: Interaction of human hematopoietic stem cells with bacterial pathogens. Blood 100, 3703–3709 (2002). https://doi.org/10.1182/blood-2002-03-0898
Fiorentini, C., Falzano, L., Fabbri, A., Stringaro, A., Logozzi, M., Travaglione, S., et al.: Activation of rho GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cells. Mol. Biol. Cell 12, 2061–2073 (2001). https://doi.org/10.1091/mbc.12.7.2061
Steinman, R.M., Swanson, J.: The endocytic activity of dendritic cells. J Exp Med. United States 182, 283–288 (1995)
Sallusto, F., Cella, M., Danieli, C., Lanzavecchia, A.: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389–400 (1995). https://doi.org/10.1084/jem.182.2.389
Kerr, M.C., Teasdale, R.D.: Defining macropinocytosis. Traffic 364–371 (2009). https://doi.org/10.1111/j.1600-0854.2009.00878.x
Rima, W., Sancey, L., Aloy, M.T., Armandy, E., Alcantara, G.B., Epicier, T., et al.: Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles. Biomaterials 34, 181–195 (2013). https://doi.org/10.1016/j.biomaterials.2012.09.029
Kumari, S., Mg, S., Mayor, S.: Endocytosis unplugged: multiple ways to enter the cell. Cell Res. 256–275 (2010). https://doi.org/10.1038/cr.2010.19
Kirchhausen, T.: Clathrin. Annu. Rev. Biochem. 69, 699–727 (2000). https://doi.org/10.1146/annurev.biochem.69.1.699
Sandvig, K., Pust, S., Skotland, T., van Deurs, B.: Clathrin-independent endocytosis: mechanisms and function. Curr. Opin. Cell Biol. 413–420 (2011). https://doi.org/10.1016/j.ceb.2011.03.007
Ford, M.G.J., Mills, I.G., Peter, B.J., Vallis, Y., Praefcke, G.J.K., Evans, P.R., et al.: Curvature of clathrin-coated pits driven by epsin. Nature 419, 361–366 (2002). https://doi.org/10.1038/nature01020
Capraro, B.R., Shi, Z., Wu, T., Chen, Z., Dunn, J.M., Rhoades, E., et al.: Kinetics of endophilin N-BAR domain dimerization and membrane interactions. J. Biol. Chem. 288, 12533–12543 (2013). https://doi.org/10.1074/jbc.M112.435511
Tebar, F., Bohlander, S.K., Sorkin, A.: Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol. Biol. Cell 10, 2687–2702 (1999). https://doi.org/10.1091/mbc.10.8.2687
Marsh, M., McMahon, H.T.: The structural era of endocytosis. Science 215–220 (1999). https://doi.org/10.1126/science.285.5425.215
Stowell, M.H., Marks, B., Wigge, P., McMahon, H.T.: Nucleotide-dependent conformational changes in dynamin: evidence for a mechanochemical molecular spring. Nat. Cell Biol. 1, 27–32 (1999). https://doi.org/10.1038/8997
Harush-Frenkel, O., Rozentur, E., Benita, S., Altschuler, Y.: Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromol 9, 435–443 (2008). https://doi.org/10.1021/bm700535p
Oh, P., Borgström, P., Witkiewicz, H., Li, Y., Borgström, B.J., Chrastina, A., et al.: Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat. Biotechnol. 25, 327–337 (2007). https://doi.org/10.1038/nbt1292
Wang, Z., Tiruppathi, C., Minshall, R.D., Malik, A.B.: Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS Nano 3, 4110–4116 (2009). https://doi.org/10.1021/nn9012274
Hommelgaard, A.M., Roepstorff, K., Vilhardt, F., Torgersen, M.L., Sandvig, K., van Deurs, B.: Caveolae: stable membrane domains with a potential for internalization. Traffic 720–724 (2005). https://doi.org/10.1111/j.1600-0854.2005.00314.x
Howes, M.T., Kirkham, M., Riches, J., Cortese, K., Walser, P.J., Simpson, F., et al.: Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells. J. Cell Biol. 190, 675–691 (2010). https://doi.org/10.1083/jcb.201002119
Parton, R.G., Simons, K.: The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 185–194 (2007). https://doi.org/10.1038/nrm2122
Pelkmans, L., Püntener, D., Helenius, A.: Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science (80-) 296, 535–539 (2002). https://doi.org/10.1126/science.1069784
Hayer, A., Stoeber, M., Ritz, D., Engel, S., Meyer, H.H., Helenius, A.: Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. J. Cell Biol. 191, 615–629 (2010). https://doi.org/10.1083/jcb.201003086
Parton, R.G., Howes, M.T.: Revisiting caveolin trafficking: the end of the caveosome. J. Cell Biol. 439–441 (2010). https://doi.org/10.1083/jcb.201009093
Gratton, S.E.A., Ropp, P.A., Pohlhaus, P.D., Luft, J.C., Madden, V.J., Napier, M.E., et al.: The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. 105, 11613–11618 (2008). https://doi.org/10.1073/pnas.0801763105
Sandvig, K., Torgersen, M.L., Raa, H.A., Van Deurs, B.: Clathrin-independent endocytosis: from nonexisting to an extreme degree of complexity. Histochem. Cell Biol. 267–276 (2008). https://doi.org/10.1007/s00418-007-0376-5
Robertson, A.S., Smythe, E., Ayscough, K.R.: Functions of actin in endocytosis. Cellu. Mol. Life Sci. 2049–2065 (2009). https://doi.org/10.1007/s00018-009-0001-y
Rothen-Rutishauser, B., Mühlfeld, C., Blank, F., Musso, C., Gehr, P.: Translocation of particles and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial airway model. Part Fibre Toxicol. 4 (2007). https://doi.org/10.1186/1743-8977-4-9
Rothen-Rutishauser, B., Schurch, S., Gehr, P.: Interaction of particles with membranes. In: Donaldson, K., Borm, P. (eds.) Particle Toxicology, pp. 139–160. CRC Press, Tyler & Francis Group, Boca Raton, FL (2007)
Xu, S., Olenyuk, B.Z., Okamoto, C.T., Hamm-Alvarez, S.F.: Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv. Drug Deliv. Rev. 65, 121–138 (2013). https://doi.org/10.1016/j.addr.2012.09.041
Low, P.S., Kularatne, S.A.: Folate-targeted therapeutic and imaging agents for cancer. Curr. Opin. Chem. Biol. 13, 256–262 (2009). https://doi.org/10.1016/j.cbpa.2009.03.022
Muller, C., Schibli, R.: Prospects in folate receptor-targeted radionuclide therapy. Front Oncol. 3, 249 (2013). https://doi.org/10.3389/fonc.2013.00249
Xia, W., Hilgenbrink, A.R., Matteson, E.L., Lockwood, M.B., Cheng, J.X., Low, P.S.: A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 113, 438–446 (2009). https://doi.org/10.1182/blood-2008-04-150789
Ross, J.F., Wang, H., Behm, F.G., Mathew, P., Wu, M., Booth, R., et al.: Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer 85, 348–357 (1999). http://www.ncbi.nlm.nih.gov/pubmed/10023702
Low, P.S., Henne, W.A., Doorneweerd, D.D.: Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc. Chem. Res. 41, 120–129 (2008). https://doi.org/10.1021/ar7000815
Zhao, X., Li, H., Lee, R.J.: Targeted drug delivery via folate receptors. Expert Opin. Drug Deliv. 5, 309–319 (2008). https://doi.org/10.1517/17425247.5.3.309
Werner, M.E., Karve, S., Sukumar, R., Cummings, N.D., Copp, J.A., Chen, R.C., et al.: Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis. Biomaterials 32, 8548–8554 (2011). https://doi.org/10.1016/j.biomaterials.2011.07.067
Ponka, P., Lok, C.N.: The transferrin receptor: role in health and disease. Int. J. Biochem. Cell. Biol. 31, 1111–1137 (1999). http://www.ncbi.nlm.nih.gov/pubmed/10582342
Sadat Tabatabaei Mirakabad, F., Nejati-Koshki, K., Akbarzadeh, A., Yamchi, M.R., Milani, M., Zarghami, N., et al.: PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac. J. Cancer Prev. 15, 517–535 (2014)
Danhier, F., Feron, O., Preat, V.: To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control Release 148, 135–146 (2010). https://doi.org/10.1016/j.jconrel.2010.08.027
van der Meel, R., Vehmeijer, L.J., Kok, R.J., Storm, G., van Gaal, E.V.: Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. Adv. Drug Deliv. Rev. 65, 1284–1298 (2013). https://doi.org/10.1016/j.addr.2013.08.012
Mirghani, H., Amen, F., Moreau, F., Guigay, J., Hartl, D.M., Lacau St Guily, J.: Oropharyngeal cancers: relationship between epidermal growth factor receptor alterations and human papillomavirus status. Eur. J. Cancer 50, 1100–1111 (2014). https://doi.org/10.1016/j.ejca.2013.12.018
Holbro, T., Civenni, G., Hynes, N.E.: The ErbB receptors and their role in cancer progression. Exp. Cell Res. 284, 99–110 (2003). http://www.ncbi.nlm.nih.gov/pubmed/12648469
Lurje, G., Lenz, H.J.: EGFR signaling and drug discovery. Oncology 77, 400–410 (2009). https://doi.org/10.1159/000279388
Harris, R.C., Chung, E., Coffey, R.J.: EGF receptor ligands. Exp. Cell Res. 284, 2–13 (2003). http://www.ncbi.nlm.nih.gov/pubmed/12648462
Tseng, C.L., Su, W.Y., Yen, K.C., Yang, K.C., Lin, F.H.: The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 30, 3476–3485 (2009). https://doi.org/10.1016/j.biomaterials.2009.03.010
Rajasekaran, A.K., Anilkumar, G., Christiansen, J.J.: Is prostate-specific membrane antigen a multifunctional protein? Am. J. Physiol. Cell Physiol. 288, C975–C981 (2005). https://doi.org/10.1152/ajpcell.00506.2004
Schulke, N., Varlamova, O.A., Donovan, G.P., Ma, D., Gardner, J.P., Morrissey, D.M., et al.: The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 100, 12590–12595 (2003). https://doi.org/10.1073/pnas.1735443100
Hrkach, J., Von Hoff, D., Mukkaram Ali, M., Andrianova, E., Auer, J., Campbell, T., et al.: Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci. Trans. Med. 4, 128ra39 (2012). https://doi.org/10.1126/scitranslmed.3003651
Tucker, G.C.: Integrins: molecular targets in cancer therapy. Curr. Oncol. Rep. 8, 96–103 (2006). http://www.ncbi.nlm.nih.gov/pubmed/16507218
Gottschalk, K.E., Kessler, H.: The structures of integrins and integrin-ligand complexes: implications for drug design and signal transduction. Angew. Chem. Int. Ed. Engl. 41, 3767–3774 (2002). https://doi.org/10.1002/1521-3773(20021018)41:20%3c3767:AID-ANIE3767%3e3.0.CO;2-T
Eliceiri, B.P., Cheresh, D.A.: Role of alpha v integrins during angiogenesis. Cancer J. 6(Suppl 3), S245–9 (2000). http://www.ncbi.nlm.nih.gov/pubmed/10874494
Brooks, P.C., Stromblad, S., Sanders, L.C., von Schalscha, T.L., Aimes, R.T., Stetler-Stevenson, W.G., et al.: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alphavbeta3. Cell 85, 683–693 (1996). http://www.ncbi.nlm.nih.gov/pubmed/8646777
Liu, S.: Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. Bioconjug. Chem. 20, 2199–2213 (2009). https://doi.org/10.1021/bc900167c
Auzzas, L., Zanardi, F., Battistini, L., Burreddu, P., Carta, P., Rassu, G., et al.: Targeting alphavbeta3 integrin: design and applications of mono- and multifunctional RGD-based peptides and semipeptides. Curr. Med. Chem. 17, 1255–1299 (2010). http://www.ncbi.nlm.nih.gov/pubmed/20166941
Graf, N., Bielenberg, D.R., Kolishetti, N., Muus, C., Banyard, J., Farokhzad, O.C., et al.: alpha(V)beta(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. ACS Nano 6, 4530–4539 (2012). https://doi.org/10.1021/nn301148e
Brambell, F.W.: The transmission of immune globulins from the mother to the foetal and newborn young. Proc. Nutr. Soc. 28, 35–41 (1969). http://www.ncbi.nlm.nih.gov/pubmed/4182340
Pridgen, E.M., Alexis, F., Kuo, T.T., Levy-Nissenbaum, E., Karnik, R., Blumberg, R.S., et al.: Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery. Sci. Transl. Med. 5, 213ra167 (2013). https://doi.org/10.1126/scitranslmed.3007049
Goldberg, M., Gomez-Orellana, I.: Challenges for the oral delivery of macromolecules. Nat. Rev. Drug Discov. 2, 289–295 (2003). https://doi.org/10.1038/nrd1067
Borner, M.M., Schoffski, P., de Wit, R., Caponigro, F., Comella, G., Sulkes, A., et al.: Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur. J. Cancer 38, 349–358 (2002). http://www.ncbi.nlm.nih.gov/pubmed/11818199
Priem, B., Tian, C., Tang, J., Zhao, Y., Mulder, W.J.: Fluorescent nanoparticles for the accurate detection of drug delivery. Expert Opin. Drug Deliv. 12, 1881–1894 (2015). https://doi.org/10.1517/17425247.2015.1074567
Wei, Q., Qi, H., Luo, W., Tseng, D., Ki, S.J., Wan, Z., et al.: Fluorescent imaging of single nanoparticles and viruses on a smart phone. ACS Nano 7, 9147–9155 (2013). https://doi.org/10.1021/nn4037706
Jin, S., Hu, Y., Gu, Z., Liu, L., Wu, H.-C.: Application of quantum dots in biological imaging. J. Nanomater. 2011, 1–13 (2011). https://doi.org/10.1155/2011/834139
He, X., Ma, N.: An overview of recent advances in quantum dots for biomedical applications. Coll. Surf. B Biointerfaces 124, 118–131 (2014). https://doi.org/10.1016/j.colsurfb.2014.06.002
Michalet, X., Pinaud, F.F., Bentolila, L.A., Tsay, J.M., Doose, S., Li, J.J., et al.: Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538–544 (2005). https://doi.org/10.1126/science.1104274
Bagalkot, V., Zhang, L., Levy-Nissenbaum, E., Jon, S., Kantoff, P.W., Langery, R., et al.: Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on Bi-fluorescence resonance energy transfer. Nano Lett. 7, 3065–3070 (2007). https://doi.org/10.1021/nl071546n
Fontes, A., de Lira, R.B., Seabra, M.A.B.L., da Silva, T.G., Castro Neto, A.G., Santos, B.S.: Quantum dots in biomedical research, biomedical engineering—technical applications in medicine [Internet]. In: Hudak, R. (ed.) InTech. https://www.intechopen.com/books/biomedical-engineering-technical-applications-in-medicine/quantum-dots-in-biomedical-research (2012)
England, C.G., Huang, J.S., James, K.T., Zhang, G., Gobin, A., Frieboes, H.B.: Detection of phosphatidylcholine-coated gold nanoparticles in orthotopic pancreatic adenocarcinoma using hyperspectral imaging. PLoS One 10 (2015). https://doi.org/10.1371/journal.pone.0129172
Guggenheim, E.J., Khan, A., Pike, J., Chang, L., Lynch, I., Rappoport JZ. Comparison of confocal and super-resolution reflectance imaging of metal oxide nanoparticles. PLoS One 11 (2016). https://doi.org/10.1371/journal.pone.0159980
Repenko, T., Rix, A., Ludwanowski, S., Go, D., Kiessling, F., Lederle, W., et al.: Bio-degradable highly fluorescent conjugated polymer nanoparticles for bio-medical imaging applications. Nat. Commun. 8 (2017). https://doi.org/10.1038/s41467-017-00545-0
Wolfbeis, O.S.: An overview of nanoparticles commonly used in fluorescent bioimaging. Chem. Soc. Rev. 44, 4743–4768 (2015). https://doi.org/10.1039/C4CS00392F
Chen, X., Cui, J., Sun, H., Mullner, M., Yan, Y., Noi, K.F., et al.: Analysing intracellular deformation of polymer capsules using structured illumination microscopy. Nanoscale 8, 11924–11931 (2016). https://doi.org/10.1039/c6nr02151d
Fytianos, K., Rodriguez-Lorenzo, L., Clift, M.J.D., Blank, F., Vanhecke, D., von Garnier, C., et al.: Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomed. Nanotechnol. Biol. Med. 11 (2015). https://doi.org/10.1016/j.nano.2014.11.004
Lehmann, A.D., Parak, W.J., Zhang, F., Ali, Z., Röcker, C., Nienhaus, G.U., et al.: Fluorescent-magnetic hybrid nanoparticles induce a dose-dependent increase in proinflammatory response in lung cells in vitro correlated with intracellular localization. Small 6, 753–762 (2010)
Blom, R.A.M., Amacker, M., Moser, C., van Dijk, R.M., Bonetti, R., Seydoux, E., et al.: Virosome-bound antigen enhances DC-dependent specific CD4+T cell stimulation, inducing a Th1 and Treg profile in vitro. Nanomed. Nanotechnol. Biol. Med. 13 (2017). https://doi.org/10.1016/j.nano.2017.02.004
Seydoux, E., Rothen-Rutishauser, B., Nita, I.M., Balog, S., Gazdhar, A., Stumbles, P.A., et al.: Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation. Int. J. Nanomed. 9 (2014). https://doi.org/10.2147/ijn.s64353
Hemmerich, P.H., von Mikecz, A.H.: Defining the subcellular interface of nanoparticles by live-cell imaging. PLoS One 8 (2013). https://doi.org/10.1371/journal.pone.0062018
De Los, S.C., Chang, C.-W., Mycek, M.-A., Cardullo, R.A.: FRAP, FLIM, and FRET: detection and analysis of cellular dynamics on a molecular scale using fluorescence microscopy. Mol. Reprod. Dev. 82, 587–604 (2015). https://doi.org/10.1002/mrd.22501
Basuki, J.S., Duong, H.T.T., Macmillan, A., Erlich, R.B., Esser, L., Akerfeldt, M.C., et al.: Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release. ACS Nano 7, 10175–10189 (2013). https://doi.org/10.1021/nn404407g
Welsher, K., Yang, H.: Multi-resolution 3D visualization of the early stages of cellular uptake of peptide-coated nanoparticles. Nat. Nanotechnol. 9, 198–203 (2014). https://doi.org/10.1038/nnano.2014.12
Van Der Zwaag, D., Vanparijs, N., Wijnands, S., De Rycke, R., De Geest, B.G., Albertazzi, L.: Super resolution imaging of nanoparticles cellular uptake and trafficking. ACS Appl. Mater. Interfaces 8, 6391–6399 (2016). https://doi.org/10.1021/acsami.6b00811
Bon, P., Bourg, N., Lécart, S., Monneret, S., Fort, E., Wenger, J., et al.: Three-dimensional nanometre localization of nanoparticles to enhance super-resolution microscopy. Nat. Commun. 6 (2015). https://doi.org/10.1038/ncomms8764
Peuschel, H., Ruckelshausen, T., Cavelius, C., Kraegeloh, A.: Quantification of internalized silica nanoparticles via STED microscopy. Biomed. Res. Int. 2015 (2015). https://doi.org/10.1155/2015/961208
Rodriguez-Lorenzo, L., Fytianos, K., Blank, F., Von Garnier, C., Rothen-Rutishauser, B., Petri-Fink, A.: Fluorescence-encoded gold nanoparticles: library design and modulation of cellular uptake into dendritic cells. Small 10, 1341–1350 (2014). https://doi.org/10.1002/smll.201302889
Clift, M.J.D., Fytianos, K., Vanhecke, D., Hočevar, S., Petri-Fink, A., Rothen-Rutishauser, B.: A novel technique to determine the cell type specific response within an in vitro co-culture model via multi-colour flow cytometry. Sci. Rep. 7, 434 (2017). https://doi.org/10.1038/s41598-017-00369-4
Mills, N., Rnqvist, H.T., Gonzalez, M., Vink, E., Robinson, S., Soderberg, S., et al.: Ischaemic and thrombotic effects of dilute diesel exhaust inhalation in patients with coronary heart disease: mechanisms for the adverse cardiovascular effects of air pollution. Heart 93, A9–A9 (2007)
Clark, R.T.: Imaging flow cytometry enhances particle detection sensitivity for extracellular vesicle analysis. Nat. Methods. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved; 12 (2015). http://dx.doi.org/10.1038/nmeth.f.380
Vanhecke, D., Rodriguez-Lorenzo, L., Clift, M.J.D., Blank, F., Petri-Fink, A., Rothen-Rutishauser, B.: Quantification of nanoparticles at the single-cell level: an overview about state-of-the-art techniques and their limitations. Nanomedicine 9 (2014). https://doi.org/10.2217/nnm.14.108
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fytianos, K., Blank, F., Müller, L. (2019). Cellular Uptake Mechanisms and Detection of Nanoparticle Uptake by Advanced Imaging Methods. In: Gehr, P., Zellner, R. (eds) Biological Responses to Nanoscale Particles. NanoScience and Technology. Springer, Cham. https://doi.org/10.1007/978-3-030-12461-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-12461-8_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-12460-1
Online ISBN: 978-3-030-12461-8
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)